EVALUATION OF PROCASPASE-ACTIVATING COMPOUND-1 IN COMBINATION WITH CHEMOTHERAPY, MEK INHIBITION, AND/OR RADIOTHERAPY FOR MALIGNANT PERIPHERAL NERVE SHEATH TUMORS

The Johns Hopkins University

Investigators